Recently there has been some talk about the spread of infection of a bacteria called Carbapenem-Resistant Enterobacteriaceae (CRE) through a procedure called an endoscopic retrograde cholangiopancreatography (ERCP).
We would like our patients to know that this does not apply to colonoscopy or upper endoscopy performed at Carolina Mountain Endoscopy Center. Our equipment is different from the one used for the ERCP procedure and this makes them easier to clean and disinfect. We are performing random quality checks on our scopes here using a product called Channel Check. So far, all have been negative for the CRE bug. ERCP's are hospital based procedures.
The FDA has released an update recommending patients not to cancel their ERCP procedures. The risk of CRE is minimal compared to the benefits of the procedure. Our physicians who perform these ERCP procedures at the hospitals are aware of this risk and are taking every measure to reduce the risk of infection.
Click here to read more about the FDA announcement.
Also Read this letter from the AGA, ASGE, ACG, AASLD and SAGES. These are various groups and organizations for GI health.